首页1PG • FRA
add
Aker Biomarine ASA
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
收入 | 5080.00万 | 4.74% |
经营支出 | 2020.00万 | -11.79% |
净收入 | -310.00万 | 73.95% |
净利润率 | -6.10 | 75.14% |
每股收益 | — | — |
息税折旧摊销前利润 | 410.00万 | -57.73% |
有效税率 | -42.86% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1600.00万 | -50.00% |
总资产 | 3.90亿 | -52.11% |
负债总额 | 2.19亿 | -52.27% |
权益总额 | 1.71亿 | — |
发行在外的股份 | 8768.50万 | — |
市净率 | 2.85 | — |
资产回报率 | -0.13% | — |
资本回报率 | -0.15% | — |
现金流
现金净变动
| (USD) | 2025年3月info | 年同比变化 |
|---|---|---|
净收入 | -310.00万 | 73.95% |
来自运营的现金 | -1090.00万 | -626.67% |
投资现金 | -260.00万 | 43.48% |
融资现金 | 1450.00万 | 38.10% |
现金净变动 | 100.00万 | -77.27% |
自由现金流 | -1113.75万 | -474.37% |
简介
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange. Wikipedia
成立时间
2006
员工数量
249
